Cargando…
A toxic organic solvent-free technology for the preparation of PEGylated paclitaxel nanosuspension based on human serum albumin for effective cancer therapy
Clinically, paclitaxel (PTX) is one of most commonly prescribed therapies against a wide range of solid neoplasms. Despite its success, the clinical applicability of PTX (Taxol(®)) is severely hampered by systemic toxicities induced by Cremophor EL. While attempts to bypass the need for Cremophor EL...
Autores principales: | Yin, Tingjie, Dong, Lihui, Cui, Bei, Wang, Lei, Yin, Lifang, Zhou, Jianping, Huo, Meirong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686322/ https://www.ncbi.nlm.nih.gov/pubmed/26715846 http://dx.doi.org/10.2147/IJN.S92697 |
Ejemplares similares
-
Amorphous Nanosuspensions Aggregated from Paclitaxel–Hemoglobulin Complexes with Enhanced Cytotoxicity
por: Qin, Chao, et al.
Publicado: (2018) -
Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment
por: Song, Yu, et al.
Publicado: (2018) -
Formulating food protein-stabilized indomethacin nanosuspensions into pellets by fluid-bed coating technology: physical characterization, redispersibility, and dissolution
por: He, Wei, et al.
Publicado: (2013) -
Mechanochemical Preparation, Characterization and Biological Activity of Stable CuS Nanosuspension Capped by Bovine Serum Albumin
por: Stahorský, Martin, et al.
Publicado: (2022) -
Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery
por: Wang, Yonglu, et al.
Publicado: (2011)